You're viewing our updated article page. If you need more time to adjust, you can return to the old layout.

CORRECTION article

Front. Immunol., 23 June 2025

Sec. Immunological Tolerance and Regulation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1632381

Correction: Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology

  • 1. Department of Fetal Medicine & Prenatal Diagnosis Center, Shanghai Key Laboratory of Maternal Fetal Medicine, Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China

  • 2. Department of Obstetrics and Gynecology, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangdong Provincial Clinical Research Center for Obstetrics and Gynecology, Guangdong-Hong Kong-Macao Greater Bay Area Higher Education Joint Laboratory of Maternal-Fetal Medicine, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China

  • 3. Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Shanghai Jiao Tong University, Shanghai, China

  • 4. Department of Obstetrics, Center of Fetal Medicine & Intrauterine Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China

  • 5. Jiaxing Maternity and Children Health Care Hospital, Affiliated Women and Children Hospital, Jiaxing University, Jiaxing, Zhejiang, China

  • 6. School of Medicine, Tongji University, Shanghai, China

Article metrics

View details

1,4k

Views

350

Downloads

In the published article, there was an error in Figure 2B as published. Incorrect values were displayed on the pie chart. The corrected Figure 2 and its caption “Figure 2 Descriptive statistics of clinical information of FGR patients. (A) Gestational Week for Collection of Maternal Peripheral Blood for FGR patients and control samples; (B) Blood flow conditions for FGR patients; (C) Combined symptoms for FGR patients” appear below.

Figure 2

Panel A is a line graph showing gestational weeks for collecting maternal peripheral blood, comparing FGR and control groups. Panel B is a pie chart depicting blood flow conditions with four segments: mild abnormalities (37%), persistent absence (43%), reversed flow (9%), and intermittent absence (11%). Panel C is a bar chart displaying combined symptoms, highlighting conditions like preeclampsia and gestational diabetes mellitus with varying frequencies.

Descriptive statistics of clinical information of FGR patients. (A) Gestational Week for Collection of Maternal Peripheral Blood for FGR patients and control samples; (B) Blood flow conditions for FGR patients; (C) Combined symptoms for FGR patients.

The original article has been updated.

Statements

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

fetal growth restriction (FGR), Olink proteomics platform, proximity extension assay (PEA), biomarkers, targeted proteomics analysis

Citation

Zhou X, Wang W, Chen L, Yang Y, Wei X, Zhou J, Sun K, Tang P, Sun X, Qin S and Sun L (2025) Correction: Investigation of potential protein biomarkers for the screening of placental-mediated fetal growth restriction disorders using targeted proteomics Olink technology. Front. Immunol. 16:1632381. doi: 10.3389/fimmu.2025.1632381

Received

21 May 2025

Accepted

05 June 2025

Published

23 June 2025

Volume

16 - 2025

Edited and reviewed by

David Cameron Wraith, University of Birmingham, United Kingdom

Updates

Copyright

*Correspondence: Shengying Qin, ; Luming Sun,

†These authors share first authorship

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics